LEAP2 and obesity disorder: To our knowledge, this is the longest study finding a decrease in fasting plasma LEAP2 with LCD (500 kcal per day deficit) with increased physical activity–induced weight loss in obesity (with T2DM) over 2 years in the SMM group.